影像增强检查静脉输注工具规范应用专家共识

2021-03-30 中国医疗设备.2021.36(3):1-5.

医学影像增强检查多经静脉高压快速团注大剂量高浓度、高渗透压、高黏滞度的对比剂,检查流速常为2.0~6.0 mL/s,甚至更高。注射时压力大、瞬间流速快,若患者血管条件差,留置针材质、型号与注射流速不匹

中文标题:

影像增强检查静脉输注工具规范应用专家共识

发布机构:

发布日期:

2021-03-30

简要介绍:

医学影像增强检查多经静脉高压快速团注大剂量高浓度、高渗透压、高黏滞度的对比剂,检查流速常为2.0~6.0 mL/s,甚至更高。注射时压力大、瞬间流速快,若患者血管条件差,留置针材质、型号与注射流速不匹配,反复穿刺,固定不当,易导致对比剂外渗甚至留置针断裂。目前,可用于对比剂高压注射的输注工具种类繁多,主要使用外周静脉留置针,血管条件差者也可使用耐高压型中心静脉导管。无论选择何种输注工具,均推荐使用耐高压输注工具。合理选择静脉输注工具,规范穿刺流程和护理流程,可以在满足患者检查需求的同时,使对比剂安全注射至患者体内。纵观国内外文献报道,暂未检索到系统的、完整的影像增强检查静脉输注规范,本共识通过成立专家组、确定研究问题、进行证据检索、内容编撰等,形成影像增强检查静脉输注工具专家共识,旨在为影像护士选择合适的输注工具提供科学依据和指引。

相关资料下载:
[AttachmentFileName(sort=1, fileName=影像增强检查静脉输注工具规范应用专家共识_.pdf)] GetToolGuiderByIdResponse(projectId=1, id=e49071c002086e8c, title=影像增强检查静脉输注工具规范应用专家共识, enTitle=, guiderFrom=中国医疗设备.2021.36(3):1-5., authorId=0, author=, summary=医学影像增强检查多经静脉高压快速团注大剂量高浓度、高渗透压、高黏滞度的对比剂,检查流速常为2.0~6.0 mL/s,甚至更高。注射时压力大、瞬间流速快,若患者血管条件差,留置针材质、型号与注射流速不匹, cover=https://img.medsci.cn/2021423/1619190462811_2020535.jpg, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Tue Mar 30 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>医学影像增强检查多经静脉高压快速团注大剂量高浓度、高渗透压、高黏滞度的对比剂,检查流速常为2.0~6.0 mL/s,甚至更高。注射时压力大、瞬间流速快,若患者血管条件差,留置针材质、型号与注射流速不匹配,反复穿刺,固定不当,易导致对比剂外渗甚至留置针断裂。目前,可用于对比剂高压注射的输注工具种类繁多,主要使用外周静脉留置针,血管条件差者也可使用耐高压型中心静脉导管。无论选择何种输注工具,均推荐使用耐高压输注工具。合理选择静脉输注工具,规范穿刺流程和护理流程,可以在满足患者检查需求的同时,使对比剂安全注射至患者体内。纵观国内外文献报道,暂未检索到系统的、完整的影像增强检查静脉输注规范,本共识通过成立专家组、确定研究问题、进行证据检索、内容编撰等,形成影像增强检查静脉输注工具专家共识,旨在为影像护士选择合适的输注工具提供科学依据和指引。</p> </div> </div> </div>, tagList=[TagDto(tagId=111677, tagName=影像增强)], categoryList=[CategoryDto(categoryId=40, categoryName=影像放射, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=3970, guiderKeyword=对比剂, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3398, appHits=87, showAppHits=0, pcHits=641, showPcHits=3311, likes=3, shares=10, comments=4, approvalStatus=1, publishedTime=Fri Apr 23 23:07:59 CST 2021, publishedTimeString=2021-03-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Fri Apr 23 23:07:49 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 08:45:08 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=影像增强检查静脉输注工具规范应用专家共识_.pdf)])
影像增强检查静脉输注工具规范应用专家共识_.pdf
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1206136, encodeId=71891206136f7, content=好好r, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1506163016, createdName=ms5000001940988320, createdTime=Sat Mar 26 16:52:54 CST 2022, time=2022-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187394, encodeId=b47c118e394bb, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/949453D13700D5D5E2170BDB0CBBEB81/100, createdBy=66e32451407, createdName=胡国宏, createdTime=Sun Jan 23 09:39:56 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078268, encodeId=e1c810e826821, content=切合临床, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Dec 09 02:25:49 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973072, encodeId=45d09e3072e5, content=切合临床, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92c343718, createdName=lm117f, createdTime=Sat Jun 12 16:53:10 CST 2021, time=2021-06-12, status=1, ipAttribution=)]
    2022-03-26 ms5000001940988320

    好好r

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1206136, encodeId=71891206136f7, content=好好r, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1506163016, createdName=ms5000001940988320, createdTime=Sat Mar 26 16:52:54 CST 2022, time=2022-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187394, encodeId=b47c118e394bb, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/949453D13700D5D5E2170BDB0CBBEB81/100, createdBy=66e32451407, createdName=胡国宏, createdTime=Sun Jan 23 09:39:56 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078268, encodeId=e1c810e826821, content=切合临床, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Dec 09 02:25:49 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973072, encodeId=45d09e3072e5, content=切合临床, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92c343718, createdName=lm117f, createdTime=Sat Jun 12 16:53:10 CST 2021, time=2021-06-12, status=1, ipAttribution=)]
    2022-01-23 胡国宏
  3. [GetPortalCommentsPageByObjectIdResponse(id=1206136, encodeId=71891206136f7, content=好好r, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1506163016, createdName=ms5000001940988320, createdTime=Sat Mar 26 16:52:54 CST 2022, time=2022-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187394, encodeId=b47c118e394bb, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/949453D13700D5D5E2170BDB0CBBEB81/100, createdBy=66e32451407, createdName=胡国宏, createdTime=Sun Jan 23 09:39:56 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078268, encodeId=e1c810e826821, content=切合临床, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Dec 09 02:25:49 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973072, encodeId=45d09e3072e5, content=切合临床, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92c343718, createdName=lm117f, createdTime=Sat Jun 12 16:53:10 CST 2021, time=2021-06-12, status=1, ipAttribution=)]
    2021-12-09 一己怀

    切合临床

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1206136, encodeId=71891206136f7, content=好好r, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1506163016, createdName=ms5000001940988320, createdTime=Sat Mar 26 16:52:54 CST 2022, time=2022-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187394, encodeId=b47c118e394bb, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/949453D13700D5D5E2170BDB0CBBEB81/100, createdBy=66e32451407, createdName=胡国宏, createdTime=Sun Jan 23 09:39:56 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078268, encodeId=e1c810e826821, content=切合临床, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Dec 09 02:25:49 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973072, encodeId=45d09e3072e5, content=切合临床, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92c343718, createdName=lm117f, createdTime=Sat Jun 12 16:53:10 CST 2021, time=2021-06-12, status=1, ipAttribution=)]
    2021-06-12 lm117f

    切合临床

    0

拓展阅读

心脏超声技师在心脏超声造影检查中的操作指南:美国超声心动图协会专项更新

美国超声心动图学会(ASE,American Society of Echocardiography) · 2015-08-01

2023 BSE实践指南:对比剂增强超声心动图

英国超声心动图学会(BSE,British Society of Echocardiography) · 2023-11-15